Buscar
Zoetis Inc
ZTSAñadir a la lista de seguimiento
76.280USD
-0.390-0.51%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
32.06BCap. mercado
12.63P/E TTM
Más Datos de Zoetis Inc Compañía
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Información de Zoetis Inc
Símbolo de cotizaciónZTS
Nombre de la empresaZoetis Inc
Fecha de salida a bolsaFeb 01, 2013
Director ejecutivoPeck (Kristin C)
Número de empleados13800
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 01
Dirección10 Sylvan Way
CiudadPARSIPPANY
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07054
Teléfono19738227000
Sitio Webhttps://www.zoetis.com/
Símbolo de cotizaciónZTS
Fecha de salida a bolsaFeb 01, 2013
Director ejecutivoPeck (Kristin C)
Ejecutivos de Zoetis Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.73K
+0.72%
Mr. Keith Sarbaugh
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
3.35K
+30.01%
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
1.96K
-216.45%
Mr. Nicholas (Nick) Ashton
Mr. Nicholas (Nick) Ashton
Executive Vice President, President - Global Manufacturing and Supply
Executive Vice President, President - Global Manufacturing and Supply
1.82K
+39.96%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Parasiticides
2.34B
24.73%
Vaccines
1.96B
20.69%
Dermatology
1.75B
18.53%
Anti-infectives
1.04B
10.94%
Pain and sedation
840.00M
8.87%
Otro
1.54B
16.24%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
5.10B
53.84%
Other emerging markets
913.00M
9.64%
Other Developed
641.00M
6.77%
Brazil
393.00M
4.15%
Australia
329.00M
3.48%
Otro
2.09B
22.12%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Parasiticides
2.34B
24.73%
Vaccines
1.96B
20.69%
Dermatology
1.75B
18.53%
Anti-infectives
1.04B
10.94%
Pain and sedation
840.00M
8.87%
Otro
1.54B
16.24%
Estadísticas de accionistas
Actualizado: lun., 11 de may
Actualizado: lun., 11 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Vanguard Capital Management, LLC
6.22%
Vanguard Portfolio Management, LLC
5.72%
BlackRock Institutional Trust Company, N.A.
5.67%
State Street Investment Management (US)
4.72%
State Farm Insurance Companies
4.03%
Otro
73.64%
Accionistas
Accionistas
Proporción
Vanguard Capital Management, LLC
6.22%
Vanguard Portfolio Management, LLC
5.72%
BlackRock Institutional Trust Company, N.A.
5.67%
State Street Investment Management (US)
4.72%
State Farm Insurance Companies
4.03%
Otro
73.64%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.32%
Investment Advisor/Hedge Fund
33.37%
Research Firm
4.22%
Insurance Company
4.11%
Pension Fund
2.87%
Bank and Trust
2.61%
Hedge Fund
1.45%
Sovereign Wealth Fund
1.44%
Individual Investor
0.08%
Participación institucional
Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q4
2795
428.61M
99.51%
--
2026Q1
3406
423.47M
101.00%
-18.24M
2025Q4
3335
436.13M
98.96%
-14.08M
2025Q3
3275
435.62M
98.29%
-1.39M
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
23.78M
5.63%
+982.47K
+4.31%
Dec 31, 2025
State Street Investment Management (US)
19.80M
4.69%
+149.38K
+0.76%
Dec 31, 2025
State Farm Insurance Companies
16.88M
4%
+9.70K
+0.06%
Dec 31, 2025
Wellington Management Company, LLP
11.39M
2.7%
+2.85M
+33.41%
Dec 31, 2025
Geode Capital Management, L.L.C.
11.33M
2.68%
+189.24K
+1.70%
Dec 31, 2025
Morgan Stanley Investment Management Ltd. (UK)
6.65M
1.58%
-827.17K
-11.06%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
5.84M
1.38%
+646.40K
+12.45%
Dec 31, 2025
Polen Capital Management, LLC
5.56M
1.32%
-1.95M
-26.00%
Dec 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
ProShares Pet Care ETF
9.4%
VanEck Pharmaceutical ETF
9.02%
VanEck Agribusiness ETF
7.81%
iShares U.S. Pharmaceuticals ETF
4.26%
Honeytree US Equity ETF
3.86%
First Trust NASDAQ Pharmaceuticals ETF
3.58%
Polen Capital Global Growth ETF
3.35%
State Street SPDR S&P Pharmaceuticals ETF
2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
2.47%
Themes US R&D Champions ETF
1.96%
Ver más
ProShares Pet Care ETF
Proporción9.4%
VanEck Pharmaceutical ETF
Proporción9.02%
VanEck Agribusiness ETF
Proporción7.81%
iShares U.S. Pharmaceuticals ETF
Proporción4.26%
Honeytree US Equity ETF
Proporción3.86%
First Trust NASDAQ Pharmaceuticals ETF
Proporción3.58%
Polen Capital Global Growth ETF
Proporción3.35%
State Street SPDR S&P Pharmaceuticals ETF
Proporción2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
Proporción2.47%
Themes US R&D Champions ETF
Proporción1.96%
Dividendos
Un total de
2.56B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Feb 05, 2026
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Jun 02, 2026 going ex on Apr 20, 2026
Apr 20, 2026
Jun 02, 2026
Apr 20, 2026
Dec 11, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 03, 2026 going ex on Jan 20, 2026
Jan 20, 2026
Mar 03, 2026
Jan 20, 2026
Oct 09, 2025
ZTS.NB Final Cash Dividend of gross USD 0.5 paid on Dec 02, 2025 going ex on Oct 31, 2025
Oct 31, 2025
Dec 02, 2025
Oct 31, 2025
May 21, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Sep 03, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Sep 03, 2025
Jul 18, 2025
Feb 06, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Jun 03, 2025 going ex on Apr 21, 2025
Apr 21, 2025
Jun 03, 2025
Apr 21, 2025
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Ver más
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
